NASDAQ:KZR - Kezar Life Sciences Price Target & Analyst Ratings

$3.62
-0.15 (-3.98 %)
(As of 09/19/2019 06:42 AM ET)
Today's Range
$3.55
Now: $3.62
$3.79
50-Day Range
$3.27
MA: $4.22
$5.99
52-Week Range
$2.82
Now: $3.62
$36.33
Volume42,309 shs
Average Volume107,599 shs
Market Capitalization$69.29 million
P/E RatioN/A
Dividend YieldN/A
Beta0.85

Analyst Ratings

Kezar Life Sciences (NASDAQ:KZR) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Kezar Life Sciences in the last 12 months. Their average twelve-month price target is $15.00, suggesting that the stock has a possible upside of 314.36%. The high price target for KZR is $15.00 and the low price target for KZR is $15.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $15.00$15.00$26.50$26.50
Price Target Upside: 314.36% upside234.08% upside44.41% upside44.41% upside

Kezar Life Sciences (NASDAQ:KZR) Consensus Price Target History

Kezar Life Sciences (NASDAQ:KZR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/8/2019CowenReiterated RatingBuyHigh
7/29/2019HC WainwrightInitiated CoverageBuy$15.00Low
3/12/2019William BlairReiterated RatingOutperformHigh
7/16/2018Jefferies Financial GroupInitiated CoverageBuy$23.00High
7/16/2018Wells Fargo & CoInitiated CoverageOutperform$30.00High
(Data available from 9/19/2017 forward)
This page was last updated on 9/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel